[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"content-doc-dcio6c7dcf88":3},{"user":4,"document":8,"mainDocument":27,"columnUrl":29,"subscription":30,"footer":42,"text":77},{"isAuthenticated":5,"isAdmin":5,"displayName":6,"avatarUrl":6,"nid":6,"groupLevel":7},false,"",-10,{"id":9,"fullTitle":10,"subTitle":6,"url":11,"columnId":12,"columnName":13,"columnUrl":14,"summary":6,"contentHtml":15,"mainContentHtml":6,"posterUrl":16,"createDate":17,"displayDate":18,"displayDateSlash":19,"pageviews":20,"tags":21,"hidden":5,"isSubContent":5,"replyDocOrTargetId":6,"contentType":23,"videoId":6,"liveVideoUrl":6,"duration":24,"price":24,"priceText":25,"priceBadgeText":25,"priceBadgeClass":26,"freeForMinGroupLevel":24,"redirectUrl":6,"readyToStream":5},"dcio6c7dcf88","美股HIMS今天大跌的原因","\u002Fdoc\u002Fdcio6c7dcf88","col18178739ee","美股资讯","\u002Fcol\u002Fcol18178739ee","\u003Cp>周五美股早盘，HIMS 股价大跌的原因是，美国总统特朗普表示，热门糖尿病药物Ozempic的价格可能降至每月仅150美元，引发市场震动。不过，联邦医疗保险和医疗补助服务中心(CMS)负责人Mehmet Oz随即澄清，相关价格谈判仍在进行中，尚未达成协议。\u003C\u002Fp>\u003Cp>礼来（LLY）股价一度下挫超过4%，报797.78美元，录得自8月7日以来的最大盘中跌幅。市场抛售情绪的触发点来自特朗普的最新表态——他称GLP-1明星药物Ozempic的价格“可能被压低到每月150美元”。这一言论瞬间引爆投资者对药企高毛利结构被政策干预的担忧，GLP-1赛道整体遭遇短线抛压。\u003C\u002Fp>\u003Cp>尽管联邦医疗保险和医疗补助服务中心（CMS）负责人 Mehmet Oz 随后表示，相关药价谈判尚未达成正式协议，仍处于讨论阶段，但资金已经开始提前反应，华尔街的风向是：市场更担心未来利润预期被系统性下调，而非当下是否已正式执行。\u003C\u002Fp>\u003Cp>与此同时，受益于GLP-1爆火的另一类公司——Hims & Hers Health（HIMS）也卷入舆论漩涡。公司CEO日前在社交媒体上转发了一则提到**“股票挤压（Stock Squeeze）”的言论，引发散户群体对其“引导交易情绪”的争议。更敏感的是，他在次日依照10b5-1计划自动出售了约176,000股股票，这一出售金额与此前多次卖出规模完全一致。尽管从制度角度看，这类交易属于常规机制性减持，但在GLP-1板块承压、药价不确定性放大的背景下，市场情绪选择放大解读。\u003C\u002Fp>\u003Cp>结果是—— HIMS股价当天大跌13%，与礼来形成“情绪共振杀跌”：一家是巨头担忧政策砍利润，另一家是平台型公司担忧用户\u002F投资热度阶段性见顶。\u003C\u002Fp>\u003Cp>华尔街正在重新定价：不是不看好赛道，而是在问——高毛利能守住多久？\u003C\u002Fp>\u003Cp> \u003C\u002Fp>\u003Cp>当前市场正在形成一种有代表性的交易逻辑：\u003C\u002Fp>\u003Cp>逻辑节点                                             投资者提问\u003C\u002Fp>\u003Cp>政策风险浮现                                        GLP-1药物的毛利率，未来是否仍能维持70%+？\u003C\u002Fp>\u003Cp>资本市场预期切换                                  赛道龙头（LLY\u002FNVO）是否进入周期性“定价权回调”阶段？\u003C\u002Fp>\u003Cp>平台型受益股波动加剧（如HIMS）            如果药价下降，平台型渠道是否仍有相同议价空间？\u003C\u002Fp>\u003Cp>散户情绪敏感                                        CEO社媒发言 + 10b5-1自动减持组合，是否影响市场信心？\u003C\u002Fp>","https:\u002F\u002Fstockwebsiteblob.blob.core.windows.net\u002Fweb-202510-stk\u002FUploaderkagpkuz2p5g_2025_10_17_10_51_58.jpg","2025-10-17T17:49:11.603","2025.10.17","2025\u002F10\u002F17",35031,[22],"HIMS","Article",0,"免费","success",{"id":9,"fullTitle":10,"subTitle":6,"url":11,"columnId":12,"columnName":13,"columnUrl":14,"summary":6,"contentHtml":15,"mainContentHtml":6,"posterUrl":16,"createDate":17,"displayDate":18,"displayDateSlash":19,"pageviews":20,"tags":28,"hidden":5,"isSubContent":5,"replyDocOrTargetId":6,"contentType":23,"videoId":6,"liveVideoUrl":6,"duration":24,"price":24,"priceText":25,"priceBadgeText":25,"priceBadgeClass":26,"freeForMinGroupLevel":24,"redirectUrl":6,"readyToStream":5},[22],"\u002Fcol\u002Fstocknews",{"visible":5,"marketingHtml":31,"services":32,"recentDocuments":41},"\u003Cfigure class=\"image\">\u003Ca href=\"https:\u002F\u002Fstockwe.com\u002Fdoc\u002Fdcio537efad5\" target=\"_blank\" rel=\"noopener noreferrer\">\u003Cimg style=\"display:block;margin-left:auto;margin-right:auto;\" src=\"https:\u002F\u002Fstockwewebfiles.blob.core.windows.net\u002Fweb-202408-stk\u002F1586109431mceclip0.jpg\">\u003C\u002Fa>\u003C\u002Ffigure>\u003Cdiv class=\"text-center\">\u003Ch2 class=\"card-title mx-auto\">\u003Cbr>\u003Ca target=\"_blank\" rel=\"noopener noreferrer\" href=\"https:\u002F\u002Fstockwe.com\u002Fdoc\u002Fdcio537efad5\">案例介绍：英伟达深度研究报告\u003C\u002Fa>\u003C\u002Fh2>\u003C\u002Fdiv>",[33,37],{"productId":34,"serviceName":35,"priceText":36},"prod_PPxdDdK87QaiLv","月付","$12.95美元",{"productId":38,"serviceName":39,"priceText":40},"prod_PPxeMs3bix1da5","年付","$149.00美元",[],{"links":43,"images":68,"summaryHtml":73,"aboutTitle":74,"aboutHtml":75,"copyrightHtml":76},[44,47,50,53,56,59,62,65],{"label":45,"url":46},"深度报告","\u002Fcol\u002FdepthReport",{"label":48,"url":49},"VIP会员","\u002Fplan",{"label":51,"url":52},"期权推荐","\u002FOption",{"label":54,"url":55},"低价暴涨股","\u002FPenny",{"label":57,"url":58},"常见问题","https:\u002F\u002Fstockwe.com\u002FFAQ",{"label":60,"url":61},"美股课程","\u002Fcol\u002Fvideos",{"label":63,"url":64},"免责声明","\u002Fdisclaimer",{"label":66,"url":67},"联系我们","\u002FContactUs",[69,70,71,72],"https:\u002F\u002Fstockwebsiteblob.blob.core.windows.net\u002Fweb-202509-stk\u002FUploaderzic2tuwsol2_2025_09_11_18_21_07.gif","https:\u002F\u002Fstockwebsiteblob.blob.core.windows.net\u002Fweb-202509-stk\u002FUploadercakzdvydksw_2025_09_03_09_00_56.png","https:\u002F\u002Fstockwebsiteblob.blob.core.windows.net\u002Fweb-202509-stk\u002FUploadergtjyagwvoyk_2025_09_14_08_32_05.png","https:\u002F\u002Fstockwebsiteblob.blob.core.windows.net\u002Fweb-202509-stk\u002FUploader3u0tt4jhlqh_2025_09_23_22_30_48.png","邮箱: buy@TradesMax.com 美国电话 626-378-3637","公司介绍","\u003Cp class=\"MsoNormal\">美股大数据 StockWe.com 是一个美国领先的金融和美股信息大数据提供商，紧盯华尔街金融市场和行情，2008年成立于美国硅谷，创始人是前纽约证券交易所资深分析师Ken，联合多位摩根斯坦利分析师，谷歌 Meta工程师利用AI和大数据，配合十多年美股实战经验和业内量化交易模型，每天处理千万级股票数据：挖掘潜力大牛股，捕捉期权异动大单，实时主力资金流向、机构持仓变化、川普突发新闻，精准买卖信号第一时间发到您手机APP。\u003C\u002Fp>","专业美股投资者都在这里",{"loading":78,"search":79,"searchPlaceholder":79,"hotContent":80,"draft":81,"noData":82,"searchNoData":83,"edit":84,"editVideo":85,"courseContent":86,"more":87,"buyNow":88,"subscribeNow":89,"encoding":90,"paidContent":91},"Loading...","搜索","热门内容","草稿","目前没有任何内容公布","当前检索内容没有数据","编辑","编辑视频","课程内容","更多","立即购买后观看","- 立即订阅 -","视频编码中...","付费内容"]